{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:56Z","timestamp":1786991636564,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS051588"],"award-info":[{"award-number":["NS051588"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jcin.2020.09.059","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T15:45:23Z","timestamp":1607355923000},"page":"2745-2752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure"],"prefix":"10.1016","volume":"13","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor F.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Inglessis-Azuaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenJun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McMullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoYing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng H.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuMing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando S.","family":"Buonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingMing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2020.09.059_bib1","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","article-title":"Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives","volume":"113","author":"Lijfering","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcin.2020.09.059_bib2","doi-asserted-by":"crossref","first-page":"j4452","DOI":"10.1136\/bmj.j4452","article-title":"Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis","volume":"359","author":"Croles","year":"2017","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/j.jcin.2020.09.059_bib3","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.ATV.0000174806.76629.7b","article-title":"Recurrence rate after a first venous thrombosis in patients with familial thrombophilia","volume":"25","author":"Vossen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2020.09.059_bib4","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.109.913673","article-title":"Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies","volume":"121","author":"Kenet","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2020.09.059_bib5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/01.STR.0000177881.34840.cf","article-title":"Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital","volume":"36","author":"Carod-Artal","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jcin.2020.09.059_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2015.11.006","article-title":"Thrombophilia testing in young patients with ischemic stroke","volume":"137","author":"Pahus","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.jcin.2020.09.059_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-8703(95)90212-0","article-title":"for the French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack","volume":"130","author":"Mas","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2020.09.059_bib8","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/0735-1097(94)90662-9","article-title":"Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk","volume":"23","author":"Comess","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2020.09.059_bib9","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/01.STR.31.10.2407","article-title":"Morphological and functional characteristics of patent foramen ovale and their embolic implications","volume":"31","author":"De Castro","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jcin.2020.09.059_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-117-6-461","article-title":"Patent foramen ovale as a risk factor for cryptogenic stroke","volume":"117","author":"Di Tullio","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1052-3057(03)00041-7","article-title":"Patent foramen ovale and hypercoagulability as combined risk factors for stroke","volume":"12","author":"Florez","year":"2003","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"19 suppl","key":"10.1016\/j.jcin.2020.09.059_bib12","first-page":"II171","article-title":"Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events","volume":"100","author":"Dearani","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2020.09.059_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2013.03.007","article-title":"The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease","volume":"139","author":"Ning","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jcin.2020.09.059_bib14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2004.06.056","article-title":"Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia","volume":"94","author":"Giardini","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2020.09.059_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jns.2017.04.014","article-title":"Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an inter-atrial septal aneurysm or both","volume":"377","author":"Lim","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jcin.2020.09.059_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S0317167100005825","article-title":"Recurrent stroke\/TIA in cryptogenic stroke patients with patent foramen ovale","volume":"34","author":"Casaubon","year":"2007","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jcin.2020.09.059_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2004.03.005","article-title":"Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale","volume":"101","author":"Schuchlenz","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2020.09.059_bib21","first-page":"741","article-title":"Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke","volume":"68","author":"Thanopoulos","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2020.09.059_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000229553","article-title":"Current management and risk of recurrent stroke\u00a0in cerebrovascular patients with right-to-left cardiac shunt","volume":"28","author":"Weimar","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jcin.2020.09.059_bib23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","article-title":"Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke","volume":"44","author":"Windecker","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2020.09.059_bib24","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/STROKEAHA.117.018153","article-title":"Patent foramen ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review","volume":"49","author":"Saver","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jcin.2020.09.059_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMcpc1302431","article-title":"Case records of the Massachusetts General Hospital. Case 34-2013. A 69-year-old man with dizziness and vomiting","volume":"369","author":"Ning","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib26","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"Clinical practice. Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.0000027819.19722.EE","article-title":"Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism","volume":"106","author":"Martin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2020.09.059_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jcin.2013.06.013","article-title":"Long-term experience and outcomes with transcatheter closure of patent foramen ovale","volume":"6","author":"Inglessis","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2020.09.059_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/01.STR.0000046457.54037.CC","article-title":"Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale","volume":"34","author":"Pezzini","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jcin.2020.09.059_bib30","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/STROKEAHA.106.480863","article-title":"Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale","volume":"38","author":"Botto","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jcin.2020.09.059_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.mbc.0000061288.28953.c8","article-title":"Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale","volume":"14","author":"Karttunen","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jcin.2020.09.059_bib32","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.jcin.2017.09.002","article-title":"Transcatheter patent foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials","volume":"10","author":"Mojadidi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2020.09.059_bib33","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","article-title":"Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials","volume":"39","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2020.09.059_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib36","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib37","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.09.059_bib38","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","article-title":"Patent foramen ovale and cryptogenic stroke in older patients","volume":"357","author":"Handke","year":"2007","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879820320185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879820320185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:12:31Z","timestamp":1761847951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879820320185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1936879820320185"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2020.09.059","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2020.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}